デフォルト表紙
市場調査レポート
商品コード
1519347

放射線腫瘍学市場レポート:タイプ、技術、用途、エンドユーザー、地域別、2024年~2032年

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2024-2032


出版日
発行
IMARC
ページ情報
英文 144 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
放射線腫瘍学市場レポート:タイプ、技術、用途、エンドユーザー、地域別、2024年~2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の放射線腫瘍学市場規模は2023年に81億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに145億米ドルに達し、2024年から2032年の間に6.5%の成長率(CAGR)を示すと予測しています。技術の進歩、がん罹患率の上昇、腫瘍放射線に関する意識の高まり、政府の取り組み、共同研究、新治療法の規制当局による承認、個別化医療の動向などが市場成長を促進する要因の一部です。

放射線腫瘍学市場分析:

主な市場促進要因:放射線腫瘍学市場の成長を後押ししているのは、世界中で急増するがんの有病率などの要因です。効果的で正確な治療法に対する需要の高さが、画像誘導放射線治療や陽子線治療の開発を促し、市場成長をさらに刺激しています。もう一つの動向は、統計的にがんにかかりやすい老人人口の増加です。さらに、特に発展途上国における医療センター開発への投資や、政府・民間によるがん検診・予防イニシアチブの利用が、放射線腫瘍学のシェアを押し上げています。これに伴い、研究機関や企業は革新的な放射線療法の開発のために積極的に協力しており、これが市場の成長を後押ししています。

主要市場動向:放射線腫瘍学市場の主要動向の1つは、数回に分けて高線量の放射線を照射する低分割療法や超低分割療法へのシフトです。このアプローチは患者にとって便利であり、医療費の削減にもつながります。さらに、治療計画システムにおける人工知能(AI)や機械学習(ML)の利用が拡大しており、周囲の健康な組織へのダメージを抑えながら、従来のシステムよりも患部により正確に放射線を照射する、よりオーダーメイドの投与パターンが生み出され、市場の成長を加速させています。さらに、放射線治療と手術、化学療法、免疫療法などの他の治療を組み合わせたマルチモダリティ治療が引き続き恩恵をもたらし、治療成績がさらに向上しています。これとは別に、患者のQOL(生活の質)への影響を最小限に抑える治療スケジューリングの傾向が強まっていることも、放射線腫瘍学市場の成長を後押ししています。

地理的動向:現在、北米は世界の放射線腫瘍学市場の最先端を走っています。この地域の優位性には、高度なヘルスケアインフラ、高い医療費、著名な機器メーカーの存在など、いくつかの要因が寄与しています。この地域の市場地位の高さは、積極的に進められている調査や陽子線治療センターなどの新技術導入率の高さにも起因しています。さらに、欧州の市場拡大の原動力となっているのは、がん治療の質とアクセスの重要性を強調する厳格な医療政策と大規模な公衆衛生プログラムです。放射線腫瘍学市場の分析によると、アジア太平洋は新進気鋭の地域です。ヘルスケア支出は増加傾向にあり、がんに対する認識も高まっています。中国やインドなどでは、ヘルスケア施設の整備が進んでいます。

競合情勢:市場の競合情勢は、Accuray Incorporated、Becton Dickinson and Company、Canon Inc.、Elekta、日立製作所、Icad Inc.、Ion Beam Applications、Isoray Inc.、Mevion Medical Systems Inc.、Nordion(Canada)Inc.(Sotera Health)、P-Cure Ltd.、Varian Medical Systems Inc.(Siemens Healthineers AG)、ViewRayなど、放射線腫瘍学の主要企業の存在によって特徴付けられます。

課題と機会:放射線腫瘍学市場は、先進的な放射線治療システムに関連する高コストなどの課題に直面しており、これが豊かでない地域での市場浸透を制限する可能性があります。また、新技術の承認取得には時間とコストがかかるため、規制上のハードルも大きな課題となっています。さらに、新興市場では熟練した専門家が不足しており、これが先進治療の導入を妨げています。しかし、こうした課題はチャンスでもあります。例えば、費用対効果の高い放射線治療装置の開拓は、低所得国市場への浸透に役立ちます。また、がん医療従事者向けの教育イニシアティブやトレーニングプログラムは、有資格の専門家の不足を緩和することができます。

放射線腫瘍学市場傾向:

技術の進歩

世界の放射線腫瘍学市場に影響を与える主な要因のひとつは、絶えず進歩する技術です。強度変調放射線治療(IMRT)や画像誘導放射線治療(IGRT)の誕生を含む技術開発は、がん治療を再定義し、他の健康な体細胞へのダメージを最小限に抑えながら腫瘍をより正確に標的にすることを可能にしました。例えば、IMRTでは、照射する放射線量に強弱をつけています。この技術により腫瘍医は、周囲の健康な組織の破壊を最小限に抑えながら、腫瘍の複雑な形状に合わせて放射線ビームを適合させることができます。一方、IGRTは、CTスキャンやMRIなどの特殊な画像を利用して、各治療セッションの前に腫瘍の正確な位置を特定します。IGRTでは、腫瘍の高画質画像が得られるだけでなく、検査位置の確認や複数の機械化された放射線ビームによる治療が可能です。さらに、側方治療の進歩により陽子線治療が発明されました。この治療法は、従来のX線の代わりに高エネルギーの陽子線で放射線を照射するもので、副作用を最小限に抑えながら優れた線量集中を可能にします。たとえば2024年には、核兵器関連の科学機関を中心とする中国の研究グループによって、フラッシュと呼ばれる強力な照射システムが設計されました。超高エネルギーの放射線を照射できるこのシステムは、従来の放射線治療を一変させる可能性を秘めています。

がん罹患率の上昇

世界の放射線腫瘍学市場は、主に発展途上諸国を中心とした世界全体のがん発生率の増加によって煽られています。世界保健機関(WHO)による世界のがんの発生に関する最新の報告書によると、インドでは2022年に1,410万人以上が新たにがんに罹患し、910万人以上ががんに関連して死亡しました。乳がんは、世界の疾病発生の指標として最も多く確認されており、新規疾病の10分の1以上を占めています。がんの有病率は年齢が上がるにつれて上昇します。さらに、長年知られていた可能性の変化や長年の環境の存在も、さらなる成長要因です。放射線腫瘍学の需要は、がん患者の増加によっても後押しされ、国際的に最も一般的な死因のひとつになると予測されています。

意識の高まりと政府の取り組み

がんの早期診断と早期治療の重要性に関する知識の高まり、またがん患者が質の高い治療を受けられるようにするための公共部門の積極的な取り組みと資源の配分が、放射線腫瘍学の世界の成長を促進しています。さまざまな非政府組織(NGO)や国際機関により、がんに対する患者の認識を高め、放射線治療サービスの必要性を高めるための啓発プログラムやキャンペーンが実施されています。政府の医療機関もまた、放射線サービスへのアクセスを強化し、がんの負担を軽減するために、がん対策、施設開発、支払い制度に投資しており、これが放射線腫瘍学市場の展望をさらに後押ししています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の放射線腫瘍学市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:タイプ別

  • 外部放射線治療
    • 市場動向
    • 主要セグメント
      • 線形加速器
      • コンパクトな先進放射線治療システム
      • 陽子線治療
    • 市場予測
  • 内部放射線治療
    • 市場動向
    • 主要セグメント
      • 近接放射線療法
      • 全身放射線治療
      • その他
    • 市場予測

第7章 市場内訳:技術別

  • 画像誘導放射線治療(IGRT)
    • 市場動向
    • 市場予測
  • 強度変調放射線治療(IMRT)
    • 市場動向
    • 市場予測
  • 定位放射線技術
    • 市場動向
    • 市場予測
  • 陽子線治療
    • 市場動向
    • 市場予測
  • 3D原体放射線治療(3D CRT)
    • 市場動向
    • 市場予測
  • 体積変調アーク治療(VMAT)
    • 市場動向
    • 市場予測
  • 近接放射線療法
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • 前立腺がん
    • 市場動向
    • 市場予測
  • 乳がん
    • 市場動向
    • 市場予測
  • 肺がん
    • 市場動向
    • 市場予測
  • 頭頸部がん
    • 市場動向
    • 市場予測
  • 大腸がん
    • 市場動向
    • 市場予測
  • 婦人科がん
    • 市場動向
    • 市場予測
  • 子宮頸がん
    • 市場動向
    • 市場予測
  • 陰茎がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • がん研究機関
    • 市場動向
    • 市場予測
  • 外来・放射線治療センター
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Canon Inc.
    • Elekta
    • Hitachi Ltd.
    • Icad Inc.
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion(Canada)Inc.(Sotera Health)
    • P-Cure Ltd.
    • Varian Medical Systems Inc.(Siemens Healthineers AG)
    • ViewRay
図表

List of Figures

  • Figure 1: Global: Radiation Oncology Market: Major Drivers and Challenges
  • Figure 2: Global: Radiation Oncology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Radiation Oncology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Radiation Oncology Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Radiation Oncology Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Radiation Oncology Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Radiation Oncology Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Radiation Oncology Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Radiation Oncology (External Beam Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Radiation Oncology (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Radiation Oncology (Internal Beam Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Radiation Oncology (Internal Beam Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Radiation Oncology (Image-Guided Radiotherapy (IGRT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Radiation Oncology (Image-Guided Radiotherapy (IGRT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Radiation Oncology (Intensity Modulated Radiotherapy (IMRT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Radiation Oncology (Intensity Modulated Radiotherapy (IMRT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Radiation Oncology (Stereotactic Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Radiation Oncology (Stereotactic Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Radiation Oncology (Proton Beam Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Radiation Oncology (Proton Beam Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Radiation Oncology (3D Conformal Radiotherapy (3D CRT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Radiation Oncology (3D Conformal Radiotherapy (3D CRT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Radiation Oncology (Volumetric Modulated Arc Therapy (VMAT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Radiation Oncology (Volumetric Modulated Arc Therapy (VMAT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Radiation Oncology (Brachytherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Radiation Oncology (Brachytherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Radiation Oncology (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Radiation Oncology (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Radiation Oncology (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Radiation Oncology (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Radiation Oncology (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Radiation Oncology (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Radiation Oncology (Head and Neck Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Radiation Oncology (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Radiation Oncology (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Radiation Oncology (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Radiation Oncology (Gynecological Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Radiation Oncology (Gynecological Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Radiation Oncology (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Radiation Oncology (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Radiation Oncology (Penile Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Radiation Oncology (Penile Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Radiation Oncology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Radiation Oncology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Radiation Oncology (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Radiation Oncology (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Radiation Oncology (Cancer Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Radiation Oncology (Cancer Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Radiation Oncology (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Radiation Oncology (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: North America: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: North America: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United States: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United States: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Canada: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Canada: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia-Pacific: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia-Pacific: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Europe: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Europe: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Germany: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Germany: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: France: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: France: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: United Kingdom: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: United Kingdom: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Italy: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Italy: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Spain: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Spain: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Russia: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Russia: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Latin America: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Latin America: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Brazil: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Brazil: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Mexico: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Mexico: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Others: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Others: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Middle East and Africa: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Middle East and Africa: Radiation Oncology Market: Breakup by Country (in %), 2023
  • Figure 99: Middle East and Africa: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Global: Radiation Oncology Industry: SWOT Analysis
  • Figure 101: Global: Radiation Oncology Industry: Value Chain Analysis
  • Figure 102: Global: Radiation Oncology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiation Oncology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Radiation Oncology Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Radiation Oncology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Radiation Oncology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Radiation Oncology Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Radiation Oncology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Radiation Oncology Market: Competitive Structure
  • Table 8: Global: Radiation Oncology Market: Key Players
目次
Product Code: SR112024A5805

The global radiation oncology market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032. Technological advancements, rising cancer incidence, increasing awareness regarding oncology radiation, government initiatives, and collaborations, regulatory approvals for new therapies, and the trend towards personalized medicine are some of the factors fostering the market growth.

Radiation Oncology Market Analysis:

Major Market Drivers: The radiation oncology market growth is fueled by the factors, including the surging prevalence of cancer across the globe. The high demand for effective and accurate treatment methods prompts the development of image-guided radiation therapy and proton therapy, which is further stimulating the market growth. Another trend is also the rise in the number of geriatric population that is statistically more prone to cancer. In addition, investments in the development of medical centers, especially in developing countries, and availability of government and private cancer screening and prevention initiatives are driving the radiation oncology market share. In line with this, research institutions and companies are actively joining forces for the development of innovative radiation therapies, which is favoring the market growth.

Key Market Trends: One of the key radiation oncology market trends is the shift toward hypofractionated and ultra-hypofractionated therapies, in which higher doses of radiation are given over few sessions. This approach is convenient for patients and reduces medical expenditures. Moreover, the use of artificial intelligence (AI) and machine learning (ML) in treatment planning systems is growing, producing more tailored administration patterns which deliver radiation more precisely to the affected location than traditional systems while reducing damage to surrounding healthy tissue, which is accelerating the market growth. Furthermore, multimodality treatments continue to provide a boon, combining radiation therapy with other treatments like surgery, chemotherapy, and immunotherapy, which further improves therapeutic outcomes. Apart from this, the growing trend towards therapeutic scheduling that minimizes the impact of the therapy on the patient's quality of life is driving the radiation oncology market growth.

Geographical Trends: At present, North America is at the forefront of the world's radiation oncology market. Several factors contribute to this region's dominance, including the advanced healthcare infrastructure, high healthcare spending, and the presence of prominent device manufacturers. The region's strong market position also stems from research being pursued aggressively and high rates of new technology adoption, such as proton therapy centers. Moreover, Europe's market expansion is driven by stringent healthcare policies and large-scale public health programs that stress the importance of cancer treatment quality and accessibility. As per the radiation oncology market analysis, the Asia-Pacific is an up-and-coming region. Healthcare spending is on the rise, and cancer awareness is growing. The healthcare facilities are becoming more advanced in countries such as China and India.

Competitive Landscape: The competitive landscape of the market is characterized by the presence of key radiation oncology companies, such as Accuray Incorporated, Becton Dickinson and Company, Canon Inc., Elekta, Hitachi Ltd., Icad Inc., Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion (Canada) Inc. (Sotera Health), P-Cure Ltd., Varian Medical Systems Inc. (Siemens Healthineers AG), ViewRay, etc.

Challenges and Opportunities: The radiation oncology market faces challenges such as high costs associated with advanced radiation therapy systems, which can limit market penetration in less affluent regions. Regulatory hurdles also pose significant challenges, as gaining approval for new technologies can be time-consuming and costly. Moreover, there is a shortage of skilled professionals in emerging markets, which hampers the adoption of advanced therapies. However, these challenges also present opportunities. For example, the development of cost-effective radiation therapy machines can help penetrate low-income markets. Educational initiatives and training programs for oncology care providers can alleviate the shortage of qualified professionals.

Radiation Oncology Market Trends:

Technological Advancements

One of the major factors influencing the global radiation oncology market is the continually advancing technology. Technological development, including the creation of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), have redefined the treatment of cancer, enabling more accurate targeting of tumors with minimal damage to other healthy body cells. For example, IMRT employs varied intensities in the radiation doses it administers. This technology enables oncologists to conform the radiation beams according to the complicated shape of the tumor with minimal destruction of surrounding healthy tissues. IGRT, on the other hand, utilizes specialized imagining such as CT scans or MRIs to identify the tumor's exact location before each treatment session. In addition to producing high quality images of the tumor, IGRT offers test position verification and treatment carrying out several mechanized radiation beams. Further, lateral therapy advancements have resulted in the invention of proton therapy. This therapy administers radiation with high-energy protons instead of traditional x-rays, allowing superior dose concentration with minimal side effects. For instance, in 2024, a powerful irradiation system called the Flash was designed by a Chinese research group mainly from nuclear weapons related scientific institutions. The system is capable of administering ultra-high energy radiation and has the potential to transform conventional radiotherapy.

Rising Incidence of Cancer

The global radiation oncology market is primarily fueled by an increase in cancer occurrence across the world, mainly in developing countries. According to the most recent report on the global occurrence of the disease by the World Health Organization (WHO), there were over 14.1 lakh new cancer instances and more than 9.1 lakh cancer-related deaths in India in 2022. Breast cancer was the most frequently identified measure of global occurrence of the disease, accounting for more than one-tenth of all new illnesses. The prevalence of cancer rises as people age; moreover, a change in long-known chances and the presence of longstanding environmental are additional growth factors. The radiation oncology demand is also boosted by the growing number of cancer patients, which is predicted to be one of the most common causes of death internationally.

Increasing Awareness and Government Initiatives

Rising knowledge about the importance of early cancer diagnosis and treatment, as well as public sector proactiveness and allocation of resources to ensure that cancer patients receive high-quality care, are driving the growth of radiation oncology globally. Several public awareness programs and campaigns are being implemented by various non-governmental organizations (NGOs) and international organizations to boost patient awareness of cancer and the rising need for radiation therapy services. Government health agencies are also investing in cancer control, facilities development, and payment schemes to enhance access to radiation services and reduce the cancer burden, which is further driving the radiation oncology market outlook.

Radiation Oncology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type, technology, application, and end user.

Breakup by Type:

External Beam Radiation Therapy

Linear Accelerators

Compact Advanced Radiotherapy Systems

Proton Therapy

Internal Beam Radiation Therapy

Brachytherapy

Systemic Beam Radiation Therapy

Others

External beam radiation therapy (EBRT) accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (linear accelerators, compact advanced radiotherapy systems, proton therapy) and internal beam radiation therapy (brachytherapy, systemic beam radiation therapy, and others). According to the report, external beam radiation therapy (EBRT) represented the largest segment.

Breakup by Technology:

Image-Guided Radiotherapy (IGRT)

Intensity Modulated Radiotherapy (IMRT)

Stereotactic Technology

Proton Beam Therapy

3D Conformal Radiotherapy (3D CRT)

Volumetric Modulated Arc Therapy (VMAT)

Brachytherapy

The report has provided a detailed breakup and analysis of the market based on the technology. This includes image-guided radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), stereotactic technology, proton beam therapy, 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), and brachytherapy.

Breakup by Application:

Prostate Cancer

Breast Cancer

Lung Cancer

Head and Neck Cancer

Colorectal Cancer

Gynecological Cancer

Cervical Cancer

Penile Cancer

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes prostate cancer, breast cancer, lung cancer, head and neck cancer, colorectal cancer, gynecological cancer, cervical cancer, penile cancer, and others.

Breakup by End User:

Hospitals

Cancer Research Institutes

Ambulatory and Radiotherapy Centers

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest radiation oncology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Key Questions Answered in This Report:

  • How has the global radiation oncology market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global radiation oncology market?
  • What is the impact of each driver, restraint, and opportunity on the global radiation oncology market?
  • What are the key regional markets?
  • Which countries represent the most attractive radiation oncology market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the radiation oncology market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the radiation oncology market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the radiation oncology market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the radiation oncology market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global radiation oncology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiation Oncology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Linear Accelerators
      • 6.1.2.2 Compact Advanced Radiotherapy Systems
      • 6.1.2.3 Proton Therapy
    • 6.1.3 Market Forecast
  • 6.2 Internal Beam Radiation Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Brachytherapy
      • 6.2.2.2 Systemic Beam Radiation Therapy
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Image-Guided Radiotherapy (IGRT)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intensity Modulated Radiotherapy (IMRT)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Stereotactic Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Proton Beam Therapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 3D Conformal Radiotherapy (3D CRT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Volumetric Modulated Arc Therapy (VMAT)
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Brachytherapy
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Prostate Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Breast Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lung Cancer
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Head and Neck Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Colorectal Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Gynecological Cancer
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Cervical Cancer
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Penile Cancer
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast
  • 8.9 Others
    • 8.9.1 Market Trends
    • 8.9.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cancer Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory and Radiotherapy Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accuray Incorporated
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Canon Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Elekta
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hitachi Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Icad Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Ion Beam Applications
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Isoray Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Mevion Medical Systems Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Nordion (Canada) Inc. (Sotera Health)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 P-Cure Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Varian Medical Systems Inc. (Siemens Healthineers AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis
    • 15.3.13 ViewRay
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials